Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Downes

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
BMC Urology|April 10, 2013
Successful minimally-invasive management of a case of giant prostatic hypertrophy associated with recurrent nephrogenic adenoma of the prostateRobert M Learney, Sachin Malde, Mark Downes, et al.
Journal of Vascular and Interventional Radiology : JVIR|September 10, 2005
Low-profile stent system for treatment of atherosclerotic renal artery stenosis: the GREAT trialMarc Sapoval, Markus Zähringer, Peter Pattynama, et al.
Journal of Endovascular Therapy : an Official Journal of the International Society of Endovascular Specialists|August 19, 2007
Sirolimus-eluting versus bare-metal low-profile stent for renal artery treatment (GREAT Trial): angiographic follow-up after 6 months and clinical outcome up to 2 yearsMarkus Zähringer, Marc Sapoval, Peter M T Pattynama, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
BMC Urology|April 10, 2013
Successful minimally-invasive management of a case of giant prostatic hypertrophy associated with recurrent nephrogenic adenoma of the prostateRobert M Learney, Sachin Malde, Mark Downes, et al.
Journal of Vascular and Interventional Radiology : JVIR|September 10, 2005
Low-profile stent system for treatment of atherosclerotic renal artery stenosis: the GREAT trialMarc Sapoval, Markus Zähringer, Peter Pattynama, et al.
Journal of Endovascular Therapy : an Official Journal of the International Society of Endovascular Specialists|August 19, 2007
Sirolimus-eluting versus bare-metal low-profile stent for renal artery treatment (GREAT Trial): angiographic follow-up after 6 months and clinical outcome up to 2 yearsMarkus Zähringer, Marc Sapoval, Peter M T Pattynama, et al.
Pageof 1